Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SWX/YPSN stock hub

SWX/YPSN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/YPSNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/YPSN

In the news

Latest news · SWX/YPSN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.5

P25 15.9P50 20.7P75 33.1

Trailing P/E20.3

P25 19.6P50 21.4P75 37.6

ROE27.2

P25 -6.1P50 7.9P75 17

ROIC27.6

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/YPSN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CHF

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	2,000
Employees Change	-644%
Employees Change Percent	-24.36
Enterprise value	CHF 3.9B
Exchange	SIX Swiss Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CH0019396990
Last refreshed	2026-05-10
Market cap	CHF 3.9B
Price	CHF 289
Price currency	CHF
Rev Per Employee	393,774.5x
Sector	Healthcare
Sic	3842
Symbol	swx/YPSN
Website	https://www.ypsomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.92%
EV Earnings	20.18x
EV/EBIT	16.34x
EV/EBITDA	13.37x
EV/FCF	-180.42x
EV/Sales	4.97x
FCF yield	-0.55%
Forward P/E	20.46x
P/B ratio	4.88x
P/E ratio	20.32x
P/S ratio	5x
PE Ratio10 Y	104.42x
PE Ratio3 Y	53.15x
PE Ratio5 Y	54.7x
PEG ratio	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.42%
EBITDA Margin	37.19%
Gross margin	39.29%
Gross Profit	CHF 309.5M
Gross Profit Growth	5.95%
Gross Profit Growth Q	13.1%
Gross Profit Growth3 Y	12.12%
Gross Profit Growth5 Y	17.09%
Net Income	CHF 194M
Net Income Growth	160.8%
Net Income Growth Q	326.67%
Net Income Growth Quarters	3%
Net Income Growth Years	4%
Net Income Growth3 Y	35.28%
Net Income Growth5 Y	30.49%
Pretax Margin	27.34%
Profit Margin	24.63%
Profit Per Employee	CHF 96,999
Profitable Years	24
ROA	12.53
Roa5y	3.69
ROCE	25.03
ROE	27.15
Roe5y	8.98
ROIC	27.65
Roic5y	6.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.06%
Cagr15y	12.05%
Cagr1y	-16.7%
Cagr20y	2.38%
Cagr3y	10.55%
Cagr5y	15.01%
Div CAGR10	8.2%
Div CAGR3	19.17%
Div CAGR5	13.66%
EPS Growth	160.7
EPS Growth Q	326.7
EPS Growth Quarters	3
EPS Growth Years	4
EPS Growth3 Y	35.28
EPS Growth5 Y	30.05
OCF Growth	35.1%
OCF Growth Q	94.9%
OCF Growth10 Y	14.55%
OCF Growth3 Y	9.05%
OCF Growth5 Y	10.32%
Revenue Growth	27.63x
Revenue Growth Q	11.94x
Revenue Growth Quarters	3x
Revenue Growth Years	5x
Revenue Growth3 Y	12.82x
Revenue Growth5 Y	9.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.66
Assets	CHF 1.2B
Cash	CHF 36.3M
Current Assets	CHF 370M
Current Liabilities	CHF 251.7M
Debt	CHF 10M
Debt EBITDA	CHF 0.03
Debt Equity	CHF 0.01
Debt FCF	CHF -0.46
Equity	CHF 807.2M
Interest Coverage	43.27
Liabilities	CHF 401.5M
Long Term Assets	CHF 838.7M
Long Term Liabilities	CHF 149.8M
Net Cash	CHF 26.3M
Net Cash By Market Cap	CHF 0.67
Net Debt EBITDA	CHF -0.09
Net Debt Equity	CHF -0.03
Tangible Book Value	CHF 652M
Tangible Book Value Per Share	CHF 47.78
WACC	8.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	6.34
Net Working Capital	CHF 92M
Quick ratio	0.75
Working Capital	CHF 118.3M
Working Capital Turnover	CHF -29.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	10%
Dividend Growth Years	3%
Dividend per share	CHF 2.2
Dividend Years	18
Dividend Yield	0.76%
Ex Div Date	2025-07-04
Last Dividend	CHF 2.2
Payout Frequency	Annual
Payout Ratio	15.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	117%
1Y total return	-16.69%
200-day SMA	329
3Y total return	35.11%
50-day SMA	282.3
50-day SMA vs 200-day SMA	50under200
5Y total return	101.17%
All Time High	441.5
All Time High Change	-34.59%
All Time High Date	2025-07-29
All Time Low	43.5
All Time Low Change	563.91%
All Time Low Date	2011-07-28
ATR	9.72
Beta	0.74
Beta1y	0.54
Beta2y	0.73
Ch YTD	-11.95
High	297
High52	441.5
High52 Date	2025-07-29
High52ch	-34.59%
Low	288.2
Low52	260.5
Low52 Date	2026-03-02
Low52ch	10.86%
Ma50ch	2.32%
Price vs 200-day SMA	-12.22%
RSI	53.28
RSI Monthly	44.2
RSI Weekly	42.83
Sharpe ratio	-0.62x
Sortino ratio	-0.64
Total Return	0.76%
Tr YTD	-11.95
Tr15y	451.08%
Tr1m	6.57%
Tr1w	3.59%
Tr3m	-1.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 239.6M
Operating Income Growth	94.64
Operating Income Growth Q	229.6
Operating Income Growth3 Y	40.59
Operating Income Growth5 Y	40.8
Operating margin	30.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,007,431%
Net Borrowing	-215,000,000
Shares Insiders	70.56%
Shares Institutions	10.83%
Shares Out	13,645,773
Shares Qo Q	0%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -21.7M
Average Volume	18,735.55x
Bv Per Share	59.15
CAPEX	CHF -233.4M
Ch10y	104.8
Ch15y	409.3
Ch1m	6.57
Ch1w	3.59
Ch1y	-17.13
Ch20y	42.27
Ch3m	-1.43
Ch3y	33.09
Ch5y	95.14
Ch6m	-6.39
Change	-3.48%
Change From Open	-2.43
Close	299.2
Days Gap	-1.07
Depreciation Amortization	53,315,000
Dollar Volume	5,807,479.2
Earnings Date	2026-05-20
EBIT	CHF 239.6M
EBITDA	CHF 292.9M
EPS	CHF 14.21
F Score	7
FCF	CHF -21.7M
FCF EV Yield	-0.55x
FCF Per Share	CHF -1.59
Financing CF	-246,656,000
Fiscal Year End	March
Founded	1,984
Graham Number	137.52315
Graham Upside	-52.38
Income Tax	CHF 21.3M
Investing CF	19,289,000
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-09-30
Lynch Fair Value	CHF 355
Lynch Upside	23.01
Ma150	306.7
Ma150ch	-5.85%
Ma20	285.6
Ma20ch	1.12%
Net CF	-16,013,000
Next Earnings Date	2026-05-20
Open	296
P OCF Ratio	18.62
Payment Date	2025-07-08
Position In Range	6.82
Ppne	614,518,000
Price Date	2026-05-08
Price EBITDA	CHF 13.46
Ptbv Ratio	6.04
Relative Volume	1.12x
Revenue	787,549,000x
Tax By Revenue	2.7x
Tax Rate	9.89%
Tr20y	60%
Tr6m	-6.39%
Volume	20,109
Z Score	9.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/YPSN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$2.20 annual per share

Payout ratio

+15.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+13.7%

3 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2025-07-04

Performance

SWX/YPSN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/YPSN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.8%

Share of float held by funds and institutions

Insider ownership

+70.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

SWX/YPSN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.3

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

-0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/YPSN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/YPSN stock rating?

swx/YPSN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/YPSN analysis?

The full report lives at /stocks/swx/YPSN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/YPSN?

The latest report frames swx/YPSN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/YPSN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.